PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease

P Ge, VL Dawson, TM Dawson - Molecular neurodegeneration, 2020 - Springer
That certain cell types in the central nervous system are more likely to undergo
neurodegeneration in Parkinson's disease is a widely appreciated but poorly understood …

Mitochondrial dysfunction in Parkinson's disease: new mechanistic insights and therapeutic perspectives

JS Park, RL Davis, CM Sue - Current neurology and neuroscience reports, 2018 - Springer
Abstract Purpose of Review Parkinson's disease (PD) is a complex neurodegenerative
disorder, the aetiology of which is still largely unknown. Overwhelming evidence indicates …

Mitochondria and Parkinson's disease: clinical, molecular, and translational aspects

M Borsche, SL Pereira, C Klein… - Journal of Parkinson's …, 2021 - content.iospress.com
Mitochondrial dysfunction represents a well-established player in the pathogenesis of both
monogenic and idiopathic Parkinson's disease (PD). Initially originating from the observation …

Mitochondrial dysfunction in Parkinson's disease–a key disease hallmark with therapeutic potential

MT Henrich, WH Oertel, DJ Surmeier… - Molecular …, 2023 - Springer
Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic
Parkinson's disease (PD). However, strategies aimed at ameliorating mitochondrial …

Mitochondrial dysfunction in Parkinson's disease

A Bose, MF Beal - Journal of neurochemistry, 2016 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disease. About
2% of the population above the age of 60 is affected by the disease. The pathological …

Parkinson's disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation

D Matheoud, A Sugiura, A Bellemare-Pelletier… - Cell, 2016 - cell.com
Antigen presentation is essential for establishing immune tolerance and for immune
responses against infectious disease and cancer. Although antigen presentation can be …

Mitochondrial dysfunction in Parkinson's disease—cause or consequence?

C Chen, DM Turnbull, AK Reeve - Biology, 2019 - mdpi.com
James Parkinson first described the motor symptoms of the disease that took his name over
200 years ago. While our knowledge of many of the changes that occur in this condition has …

The enigmatic endosome–sorting the ins and outs of endocytic trafficking

N Naslavsky, S Caplan - Journal of cell science, 2018 - journals.biologists.com
The early endosome (EE), also known as the sorting endosome (SE) is a crucial station for
the sorting of cargoes, such as receptors and lipids, through the endocytic pathways. The …

Reciprocal regulation of mitochondrial fission and fusion

R Sabouny, TE Shutt - Trends in biochemical sciences, 2020 - cell.com
The dynamic processes of mitochondrial fission and fusion are tightly regulated, determine
mitochondrial shape, and influence mitochondrial functions. For example, fission and fusion …

Mitophagy in Parkinson's disease: from pathogenesis to treatment

J Liu, W Liu, R Li, H Yang - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disease. The
pathogenesis of PD is complicated and remains obscure, but growing evidence suggests …